Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Announcement relating to despatch of Rule 15 proposal
04:01pm, Friday, 05'th Dec 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Alkermes plc $ALKS Position Decreased by Edgestream Partners L.P.
04:50am, Friday, 05'th Dec 2025
Edgestream Partners L.P. reduced its holdings in Alkermes plc (NASDAQ: ALKS) by 33.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Capital Fund Management S.A. Makes New $1.14 Million Investment in Alkermes plc $ALKS
04:18am, Friday, 05'th Dec 2025
Capital Fund Management S.A. bought a new stake in Alkermes plc (NASDAQ: ALKS) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange C
Fisher Asset Management LLC Sells 29,734 Shares of Alkermes plc $ALKS
04:40am, Thursday, 04'th Dec 2025
Fisher Asset Management LLC lessened its holdings in shares of Alkermes plc (NASDAQ: ALKS) by 9.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Co
Why Is Alkermes (ALKS) Down 5.5% Since Last Earnings Report?
12:31pm, Thursday, 27'th Nov 2025
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock?
Alkermes to Participate in Two Upcoming Investor Conferences
04:00pm, Tuesday, 25'th Nov 2025
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences. 8th Annual Evercore Healthcare Conference Date/Time: Wednesd
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal
10:16am, Thursday, 20'th Nov 2025
Alkermes lifts its bid to buy Avadel for $22.50 per share as its takeover fight with Lundbeck intensifies and shifts the deal's momentum.
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
10:16am, Wednesday, 19'th Nov 2025
Top-ranked stocks TakeTwo Interactive Software (TTWO), Allstate (ALL), SoFi Technologies (SOFI), Alkermes (ALKS) and Morgan Stanley (MS) are likely to beat on the bottom line in their upcoming release
Alkermes raises offer for Avadel after Lundbeck bid
06:08am, Wednesday, 19'th Nov 2025
Alkermes said on Wednesday it has sweetened its offer to buy Avadel Pharmaceuticals , beating a rival bid from Denmark's Lundbeck and valuing the sleep disorder drugmaker at up to $2.37 billion.
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
06:00am, Wednesday, 19'th Nov 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTIO
Alkermes plc (ALKS) Shareholder/Analyst Call Transcript
05:37pm, Monday, 17'th Nov 2025
Alkermes plc ( ALKS ) Shareholder/Analyst Call November 12, 2025 8:30 AM EST Company Participants Sandra Coombs - Senior Vice President of Corporate Affairs & Investor Relations Richard F. Pops - Chai
Alkermes (NASDAQ:ALKS) Stock Price Down 6.2% Following Analyst Downgrade
02:40am, Saturday, 15'th Nov 2025
Alkermes plc (NASDAQ: ALKS - Get Free Report) fell 6.2% on Friday after Wells Fargo and Company lowered their price target on the stock from $42.00 to $37.00. Wells Fargo and Company currently has an
Market Today: Data Delays, CEO Shifts, M&A and Deals
05:35pm, Friday, 14'th Nov 2025
Guru Stock PicksSteven Cohen has made the following transactions:Reduce in FLR by 57.92%Sold out in TATTAdd in GDEN by 26.14%New position in KEXValueAct Capital
Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal
11:37am, Friday, 14'th Nov 2025
Avadel Pharmaceuticals plc (NASDAQ: AVDL) on Friday received an unsolicited proposal from H. Lundbeck A/S for up to $23.00 per ordinary share.
H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal
09:40am, Friday, 14'th Nov 2025
The unsolicited bid—worth up to $2.25 billion —potentially upends Avadel's deal to be acquired by Alkermes.
